Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thrombosis × Arginine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Neoplasms 2 Malnutrition 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Thrombosis 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sexuality 1 Sexual Dysfunction, Physiological 1 Salivary Gland Neoplasms 1 Radiation Injuries 1 Protein Metabolism 1 Polycystic Ovary Syndrome 1 Pain 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Mucositis 1 Meningioma 1 Hemorrhage 1 Glioblastoma 1 Erectile Dysfunction 1 Disease 1 Diabetes Insipidus 1 Brain Neoplasms 1

Interventions

apixaban 6 Heparin, Low-Molecular-Weight 4 Enoxaparin 4 Dalteparin 4 Rivaroxaban 3 Blood Specimen Collection 3 Warfarin 2 Injections 2 Aspirin 2 Anticoagulants 2 salicylhydroxamic acid 1 palbociclib 1 fluorescein isothiocyanate-keyhole limpet hemocyanin 1 enoxaparin sodium 1 edoxaban 1 bemiparin 1 X-Rays 1 Ultrasonography 1 Tinzaparin 1 Technetium Tc 99m Sulfur Colloid 1 Standard of Care 1 Simvastatin 1 Saline Solution 1 Radiotherapy, Conformal 1 Physical Therapy Modalities 1 Photons 1 Phlebotomy 1 Paclitaxel 1 Observation 1 Musculoskeletal Manipulations 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05293041 2025-03-06

ARG-01

Sahlgrenska University Hospital

Phase 4 Completed

Diabetes Insipidus, Hemorrhage, Pain, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡